The association between US Food and Drug Administration−expedited review designations and health plan specialty drug coverage

BACKGROUND: The US Food and Drug Administration (FDA) speeds approval of important clinical advancements through 4 expedited review programs: Priority Review, Accelerated Approval, Fast Track, and Breakthrough Therapy. Whether health plans prioritize coverage of expedited drugs relative to drugs tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Panzer, Ari D, Ingham, Michael, Martin, Silas, Chambers, James D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394180/
https://www.ncbi.nlm.nih.gov/pubmed/36989444
http://dx.doi.org/10.18553/jmcp.2023.22415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394180/
https://www.ncbi.nlm.nih.gov/pubmed/36989444
http://dx.doi.org/10.18553/jmcp.2023.22415

Ejemplares similares